Journal of Antivirals & Antiretrovirals
Open Access
ISSN: 1948-5964
+44 1300 500008
ISSN: 1948-5964
+44 1300 500008
Department of Health and Data Sciences, Vestergaard, Lausanne, Switzerland
Research Article
United States Ending the Human Immunodeficiency Virus (HIV) Epidemic Plan: Evaluation of the Role of Industry Funding in Published Pre-Exposure Prophylaxis (PrEP) Literature
Author(s): Somya Gupta*, Salman Khan, Rinsa Vaheed and Reuben Granich
Background: Pre-Exposure Prophylaxis (PrEP) is integral to the US End of AIDS strategy. However, low adherence,
high costs, frequent testing and monitoring side effects make delivery of PrEP complicated. Gilead has sponsored
PrEP-related research and access as part of its marketing efforts. We review Conflict of Interests (COI) in the scientific
literature for the US PrEP-related articles to understand the potential impact of Gilead’s corporate sponsorship.
Methods: We searched PubMed for US PrEP articles published in 2018 in the top 10 medical journals and top
10 HIV/AIDS journals and abstracted information on author/institutional COI, type of COI, and favorability of
results and conclusions. We identified first three and senior authors from the articles and the leading institutions,
defined as institution of three or .. View More»
DOI:
10.35248/1948-5964.21.s22.001